We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About VeraDermics Stock

Invest in or calculate the value of your shares in VeraDermics or other pre-IPO companies through EquityZen's platform.

Get Started

VeraDermics Stock

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

About VeraDermics Stock

Founded

2019

Headquarters

New Haven, CT, US

Industries

Software, Artificial Intelligence, Data and Analytics

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus. The patch is applied like a bandage and remains on the skin for less than an hour. During that time, the microneedles, which are composed of the immune stimulators in a sustained-release polymer matrix, dissolve from the adhesive backing and are implanted into the skin. The adhesive can then be removed, leaving the microneedles to dissolve in the skin over the next few weeks. During that time, immune stimulators are steadily released directly into the wart.

VeraDermics Press Mentions

Stay in the know about the latest news on VeraDermics

VeraDermics Management

Leadership team at VeraDermics

President and Founder

Lauren Durso

Chief Executive Officer and Founder

Reid Waldman

Locked Features

Join now and verify your accreditation status to gain access to:

  • VeraDermics Current Valuation
  • VeraDermics Stock Price
  • VeraDermics Management
  • Available deals in VeraDermics and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • VeraDermics Cap Table and Funding History by Share Class and Liquidity Preferences
    • VeraDermics Revenue and Financials
    • VeraDermics Highlights
    • VeraDermics Business Model
    • VeraDermics Risk Factors
  • VeraDermics Research Report from SACRA Research
Join Now

Trading VeraDermics Stock

How to invest in VeraDermics stock?

Accredited investors can buy pre-IPO stock in companies like VeraDermics through EquityZen funds. These investments are made available by existing VeraDermics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell VeraDermics stock?

Shareholders can sell their VeraDermics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."